IL37 and psoriasis: IL-12 and IL-23 are central to the CD4+ T-cell response (normally regulating the Th1 and Th17 responses, respectively)—both cytokines are dimeric and share the p40 subunit, which can be targeted by the monoclonal antibody UST to treat psoriasis [9].